SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-008948
Filing Date
2017-05-05
Accepted
2017-05-05 08:36:15
Documents
44
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alny-10q_20170331.htm 10-Q 1561701
2 EX-31.1 alny-ex311_11.htm EX-31.1 18228
3 EX-31.2 alny-ex312_10.htm EX-31.2 18320
4 EX-32.1 alny-ex321_9.htm EX-32.1 7078
5 EX-32.2 alny-ex322_8.htm EX-32.2 7044
6 GRAPHIC g201705050027172534256.jpg GRAPHIC 34481
  Complete submission text file 0001564590-17-008948.txt   5394111

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT alny-20170331.xml EX-101.INS 1248171
8 XBRL TAXONOMY EXTENSION SCHEMA alny-20170331.xsd EX-101.SCH 31274
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alny-20170331_cal.xml EX-101.CAL 45423
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20170331_def.xml EX-101.DEF 96307
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20170331_lab.xml EX-101.LAB 245432
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20170331_pre.xml EX-101.PRE 184164
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36407 | Film No.: 17816233
SIC: 2834 Pharmaceutical Preparations